Direct Allergy's Seed - II Round

Direct Allergy raised a round of funding on March 25, 2014. Investors include Ben Franklin Technology Partners of Central & Northern PA.

Direct Allergy provides a customized allergy treatment within a physician's office through immunotherapy, a therapeutic process developed to provide an allergy sufferer symptom relief. Through the cou…

Articles about Direct Allergy's Seed - II Round: